Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trident Texofab's ROE % for the quarter that ended in Mar. 2026 was -14.46%. Trident Texofab's PB Ratio for the quarter that ended in Mar. 2026 was 1.24.
Trident Texofab's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -11.66%.
Trident Texofab ROE % Adjusted to Book Value Related Terms
Trident Texofab ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Trident Texofab's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trident Texofab ROE % Adjusted to Book Value Chart
Trident Texofab ROE % Adjusted to Book Value Competitor Comparison
For the Textile Manufacturing subindustry, Trident Texofab's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trident Texofab ROE % Adjusted to Book Value vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Trident Texofab's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Trident Texofab's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -11.66% mean?
Trident Texofab (BOM:540726) has a ROE % Adjusted to Book Value of -11.66% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Trident Texofab and its competitors.
Is Trident Texofab's ROE % Adjusted to Book Value too high?
Trident Texofab's current ROE % Adjusted to Book Value is -11.66%. Overall, Trident Texofab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's ROE % Adjusted to Book Value compare to competitors?
Trident Texofab's ROE % Adjusted to Book Value of -11.66% can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Manufacturing - Apparel & Accessories company?
A good ROE % Adjusted to Book Value depends on the Manufacturing - Apparel & Accessories industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Trident Texofab and its competitors. Trident Texofab's current ROE % Adjusted to Book Value is -11.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.35, compared to a current price of ₹32.25 — trading 49.1% below its estimated fair value. The current ROE % Adjusted to Book Value is -11.66%. Trident Texofab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current ROE % Adjusted to Book Value is -11.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Texofab (BOM:540726) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued.
The current stock price of ₹32.25 is trading 49.1% below its estimated GF Value™ of ₹63.35.
GuruFocus considers Trident Texofab to be Possible Value Trap.
Key valuation signals for BOM:540726:
ROE % Adjusted to Book Value: -11.66%
GF Value™: ₹63.35 vs. price of ₹32.25 (49.1% below fair value)
No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
64GF Score
Get the complete analysis for BOM:540726
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540726 has been successfully added to your 
